Wednesday, March 2, 2011

A Path

So, I have chosen a path, which is to begin on raloxifene. If I tolerate it well, I can ramp up to tamoxifen. If I don't, I can find another option.

My oncologist strongly advises avoiding recurrent cancers at all costs, that the 30% reduction in all recurrences is a 30% reduction in recurrent cancers, and that in younger women, recurrent cancer is not 50% mortality rate, but 100% mortality (i.e., even if one has a normal life length, it would not be anything but the cancer which ended it).

No comments:

Post a Comment